SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date or Report (Date of earliest event reported): March 18, 1997
BIOTECHNICA INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-11854 22-2344703
(State or other jurisdiction of (Commission File (I.R.S. Employer
incorporation or organization) Number) Identification No.)
4001 North War Memorial Drive, Peoria, IL 61614
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: 309/681-0300
_____________________________________________________________
(Former name or former address, if changed since last report)
ITEM 5. OTHER EVENTS
FOR IMMEDIATE RELEASE: March 18, 1997
CONTACT: Bruno Carette, President and Chief Operating Officer
Edward M. Germain, Chief Financial Officer
BioTechnica International, Inc.
4001 N. War Memorial Drive - Suite 200
Peoria, IL 61614
(309) 681-0300
BIOTECHNICA INTERNATIONAL, INC. ANNOUNCES THAT ITS
COMMON STOCK WILL BE DELISTED FROM NASDAQ-NMS
BioTechnica International, Inc. (NASDAQ: BIOT) (the "Company") has been
informed by The NASDAQ Stock Market, Inc. that the Common Stock of the
Company no longer qualifies for listing on the NASDAQ National Market
System. The Company has filed a notice of appeal of this finding to the
NASDAQ Listing Qualifications Hearings Department, which will stay the
effective date of the delisting for approximately two to three weeks.
NASDAQ attributed its decision to the fact that the Company, as of
December 31, 1996, did not maintain NASDAQ's Tangible Net Worth
requirement of $4,000,000. The Company attributed this fact primarily
to the seasonal nature of its business. At this time, the Company is
considering its alternatives, which may include the trading of its
common stock by means other than the NASDAQ--NMS, such as the
possibility of qualifying for trading on the OTC Bulletin Board service.
Although the delisting action could negatively impact the liquidity of
and market for the Company's stock, it would not have any adverse impact
on the continued operations or financial condition of the Company or its
ability to continue to supply products to its customers. According to
Bruno Carette, President and COO, "The action of NASDAQ will have no
impact on the day to day operations of the Company, nor will it affect
our ability to provide new and innovative products to our dealers and
customers."
BioTechnica International, Inc. is an agricultural products company
dedicated principally to the production and marketing of proprietary
hybrid corn, soybean, alfalfa, and other field seed products throughout
the Midwest Corn Belt region of the United States.
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BioTechnica International Inc.
By: /s/ Edward M. Germain
Date: March 18, 1997 Edward M Germain
Chief Financial Officer
